SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-17-019444
Filing Date
2017-08-01
Accepted
2017-08-01 18:29:59
Documents
2
Period of Report
2017-08-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2270
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4775
  Complete submission text file 0000899243-17-019444.txt   8376
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Issuer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address CRISPR THERAPEUTICS AG 610 MAIN STREET CAMBRIDGE MA 02139
Business Address
Ho Tony W (Reporting) CIK: 0001713637 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37923 | Film No.: 17997889